Dasatinib Attenuates Inflammatory Outcomes of the Sepsis Induced Acute Lung Injury Through mTOR Pathway

This study aimed to investigate the therapeutic potential of dasatinib, an FDA-approved drug for chronic myeloid leukemia, in sepsis-induced acute lung injury (ALI). In the in vitro part of the study, RAW 264.7 macrophages were stimulated with lipopolysaccharide (LPS), and the anti-inflammatory effects of dasatinib were assessed by measuring pro-inflammatory mediators and cytokines. In the in vivo part, ALI was induced in mice through intraperitoneal LPS injection. The researchers investigated alveolar-capillary permeability, the inflammatory response, and the therapeutic efficacy of dasatinib in ALI. Dasatinib administration was found to attenuate inflammation by inhibiting the mTOR pathway. In the in vivo experiments, dasatinib reduced the levels of pro-inflammatory cytokines and chemokines in bronchoalveolar lavage fluid (BALF). It also decreased lung tissue permeability, as evidenced by a lower amount of Evans blue dye detected after ALI. Furthermore, dasatinib alleviated lung histological damage and reduced the lung injury grade, demonstrating its protective role in ALI. By inhibiting the mTOR pathway in macrophages, dasatinib exhibited a protective and anti-inflammatory effect on ALI. It reduced the intrapulmonary inflammatory response, prevented capillary disruption, and inhibited the accumulation of inflammatory cells. These findings suggest that dasatinib holds promise as a potential treatment option for protecting lung tissue in ALI.

[1]  W. Tyagi,et al.  Playing with colours: genetics and regulatory mechanisms for anthocyanin pathway in cereals , 2021, Biotechnology & genetic engineering reviews.

[2]  Dasatinib , 2019, Reactions Weekly.

[3]  Qiaojun He,et al.  High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity. , 2018, Toxicology letters.

[4]  P. Rocco,et al.  The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma , 2016, British journal of pharmacology.

[5]  J. Yadav,et al.  MyD88 mediates in vivo effector functions of alveolar macrophages in acute lung inflammatory responses to carbon nanotube exposure. , 2015, Toxicology and applied pharmacology.

[6]  H. Ohdan,et al.  Preventive effect of G-CSF on acute lung injury via alveolar macrophage regulation. , 2012, The Journal of surgical research.

[7]  A. Mócsai,et al.  Dasatinib inhibits proinflammatory functions of mature human neutrophils , 2012, Blood.

[8]  J. Hayball,et al.  Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo. , 2009, Experimental hematology.

[9]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[10]  P. Popovich,et al.  Characterization and modeling of monocyte‐derived macrophages after spinal cord injury , 2007, Journal of neurochemistry.

[11]  A. A. Romanovsky,et al.  Neural Substrate of Cold-Seeking Behavior in Endotoxin Shock , 2006, PloS one.

[12]  J. Norrie,et al.  Acute respiratory distress syndrome: an audit of incidence and outcome in Scottish intensive care units , 2003, Anaesthesia.

[13]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[14]  T. Majima,et al.  Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. , 2002, The Journal of surgical research.

[15]  J. Roselló-Catafau,et al.  Activation of alveolar macrophages in lung injury associated with experimental acute pancreatitis is mediated by the liver. , 1999, Annals of surgery.

[16]  T. Decker,et al.  Stat1 combines signals derived from IFN‐γ and LPS receptors during macrophage activation , 1998, The EMBO journal.

[17]  J. Luce Acute lung injury and the acute respiratory distress syndrome. , 1998, Critical care medicine.

[18]  S. Moore,et al.  Diagnostic and pathogenetic considerations in transfusion‐related acute lung injury , 1985, Transfusion.

[19]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.